Found 0 matching trials
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) PHASE1 This is a phase 1b prospective, single arm, open-label trial determining th...
Show More Location
Chao Family Comprehensive Cancer Center, University
Learn More & Join Trial
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors PHASE1 The goal of this interventional clinical study is to learn the safety and p...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer PHASE1 This study is testing narmafotinib, a type of drug called a focal adhesion ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary PHASE2 there is a need for improving chemotherapy regimen for metastatic G3 NEC of...
Show More Learn More & Join Trial
A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma PHASE2 Within the next decade, pancreatic ductal adenocarcinoma (PDAC) is expected...
Show More Location
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea
Learn More & Join Trial
Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma PHASE3 Indication : Adult patients with intermediate low or mid rectal adenocarcin...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer PHASE3 Pancreatic cancer is one of the most treatment resistant malignancies, ofte...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas PHASE2 The purpose of this study is to estimate safety of GVAX Pancreas Vaccine (G...
Show More Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer N/A FOLFIRINOX regimen is first-line neoadjuvant chemotherapies for patients wi...
Show More Location
the second affiliated hospital of Zhejiang University
Learn More & Join Trial
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer PHASE3 The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Show More Location
The second affiliated hospital of Zhejiang University
Learn More & Join Trial